Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zuzana Hanulova"'
Publikováno v:
Biomedical Papers. 152:217-221
AIM: Chemerin is a novel adipokine that has been suggested to play an important role in the pathogenesis of the metabolic syndrome. The aim of our study was to evaluate serum chemerin as a marker of the metabolic syndrome and to assess its predictive
Autor:
Pavel Stejskal, David Stejskal, Zuzana Hanulova, M Petzel, Michal Karpisek, V. Humenanská, P Kusnierova
Publikováno v:
Hormone and Metabolic Research. 40:381-385
Lipocalin-2 (also known as neutrophil gelatinase-associated lipocalin [NGAL]) has been described as a promising marker of metabolic syndrome associated with inflammation. The aim of our work was to develop an assay for the determination of lipocalin-
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 68:501-507
Since fibroblast growth factor 19 (FGF-19) is a potent metabolic regulator that influences glucose and lipid homeostasis, our aim was to develop an ELISA assay for measuring FGF-19 in human serum and to investigate its concentrations in healthy volun
Autor:
Viera Humenanska, David Stejskal, Pavlina Solichova, Michal Karpisek, Zuzana Hanulova, Josef Bartek, Radka Ochmanova
Publikováno v:
ResearcherID
BACKGROUND Clusterin is a glycoprotein which participates in a number of pathophysiological processes in the organism. Information about clusterin use in the diagnosis of nephropathy and the differential diagnosis of proteinuria has been published re
Autor:
Radovan Vrtal, David Stejskal, Richard Fiala, Zuzana Hanulova, Viera Humenanska, Pavlina Solichova, Michal Karpisek
Publikováno v:
ResearcherID
Background: N1,N12-diacetylspermine, a diacetylpolyamine which was recently identified in urine, appeared to be a useful tumor marker for a number of cancers. No valid data on urine diacetylspermine concentration in patients with urinary bladder canc